ANEPSY
ActiveSummary
The annual accounts of ANEPSY for fiscal year 2025 show a net loss of 76% of the equity at the start of that year. The 2025 annual accounts show equity of €47,801 and a net result of -€152,997. Equity is shrinking by ~3.7% per year across the filed fiscal years. Its solvency ranks better than 15% of 16765 sector peers (fiscal year 2025). The company has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability2▲+2
Solvency37▼-22
Growth32=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000 at 30 days only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity tight (current ratio 1.36 against 3.66 in 2024; short-term debt: 21.1% and cash: 2.9% of total assets), and 88.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
11.8%
Return on assets
-37.7%
Age of the figures
9 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
18192022232425
2018 to 2025 · latest year -€152,997
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 16765 sector peers (2025).
NBB · sector comparisonPosition among 16765 sector peers
Solvency
better than 15%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
11 d early
2024
20 d early
2023
43 d late
2022
198 d late
2020
94 d late
2019
18 d late
2018
40 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 52 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 13 September (4 of the last 5 filed years within 64 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€47,801▼ 76.2%
2024 · €200,798
Total assets
€406,193▼ 31.3%
2024 · €590,841
Net result
-€152,997▼ 21.2%
2024 · -€126,215
Working capital
€31,118▼ 84.4%
2024 · €199,823
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202022202320242025
Operating result€44,437▼ 37.7%€88,086-€97,846▲ 11.1%-€23,713€3,839
Net result€52,153within the sector's middle half€72,630within the sector's middle half--€53,653below the sector's middle half-€126,215below the sector's middle half▼ 135%-€152,997below the sector's middle half▼ 21.2%
Equity€299,241within the sector's middle half▲ 21.1%€380,666above the sector's middle half-€327,013within the sector's middle half▼ 14.1%€200,798within the sector's middle half▼ 38.6%€47,801within the sector's middle half▼ 76.2%
Total assets€865,553above the sector's middle half▲ 2.2%€891,386above the sector's middle half-€821,715above the sector's middle half▼ 7.8%€590,841within the sector's middle half▼ 28.1%€406,193within the sector's middle half▼ 31.3%
Debt€566,312▼ 5.6%€510,721-€494,702▼ 3.1%€390,043▼ 21.2%€358,392▼ 8.1%
Working capital€307,873above the sector's middle half▲ 12.2%€351,786above the sector's middle half-€349,116above the sector's middle half▼ 0.8%€199,823within the sector's middle half▼ 42.8%€31,118within the sector's middle half▼ 84.4%
Solvency34.6%within the sector's middle half▲ 5.4pp42.7%within the sector's middle half-39.8%within the sector's middle half▼ 2.9pp34.0%below the sector's middle half▼ 5.8pp11.8%below the sector's middle half▼ 22.2pp
Current ratio2.94within the sector's middle half▲ 0.162.99within the sector's middle half-3.64within the sector's middle half▲ 0.653.66within the sector's middle half▲ 0.021.36within the sector's middle half▼ 2.29
Return on assets (ROA)6.0%within the sector's middle half▲ 6.4pp8.1%within the sector's middle half--6.5%below the sector's middle half▼ 14.7pp-21.4%below the sector's middle half▼ 14.8pp-37.7%below the sector's middle half▼ 16.3pp
Staff (FTE)
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €3,839 after a loss of €23,713 in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €406,193
Fixed assets
€289,417 ▼ 8.4%
Current assets
€116,776 ▼ 57.5%
Equity and liabilities €406,193
Equity
€47,801 ▼ 76.2%
Debt
€358,392 ▼ 8.1%
Debt's share of the balance-sheet total rises from 66.0% to 88.2%. Equity and debt are lower.
Key figures and ratios
EBITDA
€31,210▲
2024 · €3,259
Cash flow
-€125,626▼
2024 · -€99,243
Debt to equity
7.50▲
2024 · 1.94
ROE
-320.1%▼
2024 · -62.9%
Interest coverage
0.19▲
2024 · 0.03
Debt ≤ 1 year
€85,659▲
2024 · €75,178
Debt > 1 year
€272,734▼
2024 · €314,865
Income taxes
€464▼
2024 · €2,551
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 1,294 companies that looked in July 2024 the way this one looks now, 4.1% went bankrupt within 24 months and 90% are still going.
- Micro
- 10 to 20 years old
- solvency 10 to 30%
- a loss of 10% of the balance sheet or more
4.1%
went bankrupt
6.0%
stopped otherwise
90%
still going
A further 0.4% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 1,294 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €21,500 | €0 | €303 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €27,756 | €27,089 | €27,346 | €26,972 | €27,371 | ▲ 1.5% |
| Other operating charges640/8 | - | €3,101 | €29,222 | €4,409 | €7,654 | ▲ 73.6% |
| Gross operating margin9900 | €77,075 | €118,277 | €154,414 | €7,668 | €38,864 | ▲ 407% |
| Operating profit (loss)9901 | €44,437 | €88,086 | €97,846 | -€23,713 | €3,839 | ▲ 116% |
| Financial income75/76B | - | €21,943 | €15,559 | €9,460 | €5,253 | ▼ 44.5% |
| Recurring financial income75 | €27,433 | €21,943 | €15,559 | €9,460 | €5,253 | ▼ 44.5% |
| Financial charges65/66B | - | €14,402 | €167,058 | €109,411 | €161,626 | ▲ 47.7% |
| Recurring financial charges65 | €15,659 | €14,402 | €167,058 | €109,411 | €161,626 | ▲ 47.7% |
| Profit (loss) for the period before taxes9903 | €56,211 | €95,627 | -€53,653 | -€123,664 | -€152,533 | ▼ 23.3% |
| Income taxes67/77 | €4,058 | €22,997 | - | €2,551 | €464 | ▼ 81.8% |
| Profit (loss) for the period9904 | €52,153 | €72,630 | -€53,653 | -€126,215 | -€152,997 | ▼ 21.2% |
| Profit (loss) for the period to be appropriated9905 | €52,153 | €72,630 | -€53,653 | -€126,215 | -€152,997 | ▼ 21.2% |
| Line | 2020 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €865,553 | €891,386 | €821,715 | €590,841 | €406,193 | ▼ 31.3% |
| Fixed assets21/28 | €398,673 | €362,391 | €340,165 | €315,840 | €289,417 | ▼ 8.4% |
| Tangible fixed assets22/27 | €398,441 | €362,159 | €339,933 | €315,608 | €289,185 | ▼ 8.4% |
| Land and buildings22 | - | €339,244 | €315,344 | €291,444 | €267,544 | ▼ 8.2% |
| Plant, machinery and equipment23 | - | €884 | €581 | €279 | €279 | = |
| Furniture and vehicles24 | - | - | €4,527 | €5,618 | €5,206 | ▼ 7.3% |
| Other tangible fixed assets26 | - | €22,031 | €19,481 | €18,267 | €16,156 | ▼ 11.6% |
| Financial fixed assets28 | €232 | €232 | €232 | €232 | €232 | = |
| Current assets29/58 | €466,881 | €528,995 | €481,550 | €275,001 | €116,776 | ▼ 57.5% |
| Amounts receivable after more than one year29 | - | €55,068 | €53,494 | €51,830 | €45,109 | ▼ 13.0% |
| Other amounts receivable291 | - | €55,068 | €53,494 | €51,830 | €45,109 | ▼ 13.0% |
| Amounts receivable within one year40/41 | €387,550 | €449,105 | €402,267 | €199,976 | €57,238 | ▼ 71.4% |
| Trade receivables40 | - | €70,050 | €111,624 | €9,956 | €4,800 | ▼ 51.8% |
| Other amounts receivable41 | - | €379,055 | €290,643 | €190,020 | €52,438 | ▼ 72.4% |
| Cash at bank and in hand54/58 | €4,500 | €23,754 | €25,522 | €18,313 | €11,942 | ▼ 34.8% |
| Deferred charges and accrued income490/1 | - | €1,069 | €267 | €4,882 | €2,486 | ▼ 49.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €865,553 | €891,386 | €821,715 | €590,841 | €406,193 | ▼ 31.3% |
| Equity10/15 | €299,241 | €380,666 | €327,013 | €200,798 | €47,801 | ▼ 76.2% |
| Contributions10/11 | - | €6,200 | €6,200 | €6,200 | €6,200 | = |
| Reserves13 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Profit (loss) carried forward14 | €291,181 | €372,606 | €318,953 | €192,738 | €39,741 | ▼ 79.4% |
| Amounts payable17/49 | €566,312 | €510,721 | €494,702 | €390,043 | €358,392 | ▼ 8.1% |
| Amounts payable after more than one year17 | €407,305 | €329,734 | €354,829 | €314,865 | €272,734 | ▼ 13.4% |
| Financial debts170/4 | - | €329,734 | €354,829 | €314,865 | €272,734 | ▼ 13.4% |
| Amounts payable within one year42/48 | €159,008 | €177,208 | €132,434 | €75,178 | €85,659 | ▲ 13.9% |
| Current portion of amounts payable after more than one year42 | - | €84,508 | €21,670 | €11,002 | €13,343 | ▲ 21.3% |
| Financial debts43 | - | €12,000 | €12,000 | €20,789 | €20,789 | = |
| Credit institutions430/8 | - | - | €12,000 | €20,789 | €20,789 | = |
| Other loans439 | - | €12,000 | - | - | - | - |
| Trade debts44 | €13,190 | €18,675 | €23,409 | €3,388 | €9,699 | ▲ 186% |
| Suppliers440/4 | - | €18,675 | €23,409 | €3,388 | €9,699 | ▲ 186% |
| Taxes, remuneration and social security45 | - | €14,171 | €27,501 | €0 | €1,828 | - |
| Taxes450/3 | - | €10,997 | €17,260 | €0 | €1,828 | - |
| Remuneration and social security454/9 | - | €3,175 | €10,241 | €0 | - | - |
| Other amounts payable47/48 | - | €47,854 | €47,854 | €40,000 | €40,000 | = |
| Accrued charges and deferred income492/3 | - | €3,778 | €7,439 | €0 | - | - |
| Line | 2020 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €52,153 | €72,630 | -€53,653 | -€126,215 | -€152,997 | ▼ 21.2% |
| + Depreciation and write-downs630 | €27,756 | €27,089 | €27,346 | €26,972 | €27,371 | ▲ 1.5% |
| Operating cash flow (approximation) | €79,909 | €99,719 | -€26,307 | -€99,243 | -€125,626 | ▼ 26.6% |
| Investment in fixed assets (approximation) | - | - | -€5,120 | -€2,646 | -€948 | ▲ 64.2% |
| Change in cash | - | - | €1,769 | -€7,209 | -€6,370 | ▲ 11.6% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
20-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet -€152,997
Net result drops to -€152,997, the lowest in the series.
11-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
12-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 43 days late
14-02
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 198 days late
2022
31-12
Financial
Highest result since 2018net €72,630 ▲39.3%
Net result €72,630, the highest in the series.
2021
02-11
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 94 days late
2020
31-12
Financial
Back to profitnet €52,153
Net result €52,153 after 2 loss-making years.
18-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 18 days late
2019
09-09
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 40 days late
2018
25-09
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 56 days late
2017
08-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 8 days late
2016
25-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Lambrechts-Woluwe
Ground area
192 m²
Building footprint
88 m²
Volume, LiDAR
811 m³
Parcel 21018A0119/00B007, Brussels · tallest building 13.0 m, ±3 floors. Linked by address, not a title deed.
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21018A0119/00B007 | Brussels | 192 m² | 1 · 88 m² | 13.0 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
549300N35LYRFDB4EX56
Similar companies · same sector, comparable size
PNEUMOLOGIE TILLEGEM
BE 0735.959.883
Brugge · Eq €47,776
DR. VANWING V.
BE 0760.396.559
Leuven · Eq €47,903
CEDEMU
BE 0567.762.873
Profondeville · Eq €47,691
New Vision Oogkliniek Zuid Antwerpen
BE 0642.882.247
Edegem · Eq €47,932
KINNAERT MD
BE 0784.695.158
Eupen · Eq €47,944
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 5,004 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded15-10-2007
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0892875892
Also
9925:BE0892875892
Registered
18-10-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.